Published in J Am Vet Med Assoc on October 15, 2008
Quality of life assessment in domestic dogs: An evidence-based rapid review. Vet J (2015) 1.47
Use of an activity monitor to detect response to treatment in dogs with osteoarthritis. J Am Vet Med Assoc (2010) 1.14
A review of translational animal models for knee osteoarthritis. Arthritis (2012) 1.12
Evaluation of construct and criterion validity for the 'Liverpool Osteoarthritis in Dogs' (LOAD) clinical metrology instrument and comparison to two other instruments. PLoS One (2013) 1.06
Effect of analgesic therapy on clinical outcome measures in a randomized controlled trial using client-owned dogs with hip osteoarthritis. BMC Vet Res (2012) 1.06
Validation of the English version of the UNESP-Botucatu multidimensional composite pain scale for assessing postoperative pain in cats. BMC Vet Res (2013) 1.00
Clinical validity of outcome pain measures in naturally occurring canine osteoarthritis. BMC Vet Res (2012) 0.97
Serum biomarkers of clinical and cytologic response in dogs with idiopathic immune-mediated polyarthropathy. J Vet Intern Med (2014) 0.91
A canine-specific anti-nerve growth factor antibody alleviates pain and improves mobility and function in dogs with degenerative joint disease-associated pain. BMC Vet Res (2015) 0.91
Effect of a diet enriched with green-lipped mussel on pain behavior and functioning in dogs with clinical osteoarthritis. Can J Vet Res (2013) 0.89
Feasibility and repeatability of thermal quantitative sensory testing in normal dogs and dogs with hind limb osteoarthritis-associated pain. Vet J (2013) 0.87
The vanilloid agonist resiniferatoxin for interventional-based pain control. Curr Top Med Chem (2011) 0.86
The challenges of assessing osteoarthritis and postoperative pain in dogs. AAPS J (2013) 0.85
Effects of μ-opioid receptor agonists in assays of acute pain-stimulated and pain-depressed behavior in male rats: role of μ-agonist efficacy and noxious stimulus intensity. J Pharmacol Exp Ther (2014) 0.84
Pain assessment in animal models of osteoarthritis. Gene (2013) 0.82
Resiniferatoxin: The Evolution of the "Molecular Scalpel" for Chronic Pain Relief. Pharmaceuticals (Basel) (2016) 0.80
The search for novel analgesics: targets and mechanisms. F1000Prime Rep (2015) 0.79
Initial evaluation of nighttime restlessness in a naturally occurring canine model of osteoarthritis pain. PeerJ (2015) 0.78
Comparative efficacy and safety of mavacoxib and carprofen in the treatment of canine osteoarthritis. Vet Rec (2014) 0.77
Widespread somatosensory sensitivity in naturally occurring canine model of osteoarthritis. Pain (2016) 0.75
Functional outcome measures in a surgical model of hip osteoarthritis in dogs. J Exp Orthop (2016) 0.75
A Prospective, Randomized, Masked, and Placebo-Controlled Efficacy Study of Intraarticular Allogeneic Adipose Stem Cells for the Treatment of Osteoarthritis in Dogs. Front Vet Sci (2016) 0.75
Intra-Articular Hyaluronic Acid Compared to Traditional Conservative Treatment in Dogs with Osteoarthritis Associated with Hip Dysplasia. Evid Based Complement Alternat Med (2016) 0.75
Does a placebo effect really occur in dogs afflicted by hip osteoarthritis as measured by force platform gait analysis? BMC Vet Res (2013) 0.75
SP, CGRP changes in pyridoxine induced neuropathic dogs with nerve growth factor gene therapy. BMC Neurosci (2016) 0.75
A Prospective, Randomized, Masked, Placebo-Controlled Multisite Clinical Study of Grapiprant, an EP4 Prostaglandin Receptor Antagonist (PRA), in Dogs with Osteoarthritis. J Vet Intern Med (2016) 0.75
Regression to the mean: what it is and how to deal with it. Int J Epidemiol (2004) 6.29
Development and validation of a questionnaire for measuring behavior and temperament traits in pet dogs. J Am Vet Med Assoc (2003) 1.92
Development and psychometric testing of an instrument designed to measure chronic pain in dogs with osteoarthritis. Am J Vet Res (2007) 1.41
Evaluation of a behavioral assessment questionnaire for use in the characterization of behavioral problems of dogs relinquished to animal shelters. J Am Vet Med Assoc (2005) 1.22
Development of a questionnaire to measure the effects of chronic pain on health-related quality of life in dogs. Am J Vet Res (2004) 1.21
Clinical evaluation of a nutraceutical, carprofen and meloxicam for the treatment of dogs with osteoarthritis. Vet Rec (2003) 1.20
Assessing repeatability and validity of a visual analogue scale questionnaire for use in assessing pain and lameness in dogs. Am J Vet Res (2004) 1.17
Validation of a structured questionnaire as an instrument to measure chronic pain in dogs on the basis of effects on health-related quality of life. Am J Vet Res (2006) 1.14
Randomized, controlled trial of the efficacy of carprofen, a nonsteroidal anti-inflammatory drug, in the treatment of osteoarthritis in dogs. J Am Vet Med Assoc (1995) 1.14
Five-year longitudinal study on limited food consumption and development of osteoarthritis in coxofemoral joints of dogs. J Am Vet Med Assoc (1997) 1.06
Clinical evaluation of a powder of quality elk velvet antler for the treatment of osteoarthrosis in dogs. Can Vet J (2004) 1.02
A novel approach to the use of animals in studies of pain: validation of the canine brief pain inventory in canine bone cancer. Pain Med (2008) 1.01
Preliminary study on owner-reported behaviour changes associated with chronic pain in dogs. Vet Rec (2001) 0.97
Effect of weight reduction on clinical signs of lameness in dogs with hip osteoarthritis. J Am Vet Med Assoc (2000) 0.97
Randomised, double-blind, placebo-controlled parallel group study of P54FP for the treatment of dogs with osteoarthritis. Vet Rec (2003) 0.94
Estimating treatment effects in clinical trials subject to regression to the mean. Biometrics (1985) 0.92
Clinical efficacy and pharmacokinetics of carprofen in the treatment of dogs with osteoarthritis. Vet Rec (2002) 0.90
Control of selection bias in parallel-group controlled clinical trials in dogs and cats: 97 trials (2000-2005). J Am Vet Med Assoc (2006) 0.89
Sources and handling of losses to follow-up in parallel-group randomized clinical trials in dogs and cats: 63 trials (2000-2005). Am J Vet Res (2007) 0.88
A log-linear model for ordinal data to characterize differential change among treatments. Stat Med (1989) 0.85
Nutritional management of osteoarthritis. Vet Clin North Am Small Anim Pract (1997) 0.82
Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain (2005) 11.80
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain (2007) 8.89
Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain (2007) 6.98
The prevention and treatment of missing data in clinical trials. N Engl J Med (2012) 6.92
BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis. PLoS Biol (2004) 6.72
Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66
Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry (2005) 4.81
Psychological interventions for distress in cancer patients: a review of reviews. Ann Behav Med (2006) 4.60
Do ultra-short screening instruments accurately detect depression in primary care? A pooled analysis and meta-analysis of 22 studies. Br J Gen Pract (2007) 4.57
Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol (2003) 4.27
Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain (2003) 4.24
Fasting triglyceride and the triglyceride-HDL cholesterol ratio are not markers of insulin resistance in African Americans. Arch Intern Med (2005) 3.81
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol (2003) 3.80
Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA (2008) 3.55
Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation (2005) 3.33
Distress in couples coping with cancer: a meta-analysis and critical review of role and gender effects. Psychol Bull (2008) 2.87
Effects of screening for psychological distress on patient outcomes in cancer: a systematic review. J Psychosom Res (2013) 2.78
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations. Pain (2013) 2.58
Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain (2009) 2.53
Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations. Pain (2009) 2.49
Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with pain. Pain (2007) 2.47
No further research needed: abandoning the Hospital and Anxiety Depression Scale (HADS). J Psychosom Res (2012) 2.41
Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications. Am J Gastroenterol (2002) 2.39
Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations. Pain (2006) 2.23
Modifiable barriers to adherence to inhaled steroids among adults with asthma: it's not just black and white. J Allergy Clin Immunol (2003) 2.21
Comparison of objective and patient-reported hot flash measures in men with prostate cancer. J Support Oncol (2009) 2.20
Managed problem solving for antiretroviral therapy adherence: a randomized trial. JAMA Intern Med (2013) 2.16
Effects of electrostimulated acupuncture on ground reaction forces and pain scores in dogs with chronic elbow joint arthritis. J Am Vet Med Assoc (2006) 2.15
Electroacupuncture for fatigue, sleep, and psychological distress in breast cancer patients with aromatase inhibitor-related arthralgia: a randomized trial. Cancer (2014) 2.12
Is longer-term psychodynamic psychotherapy more effective than shorter-term therapies? Review and critique of the evidence. Psychother Psychosom (2010) 2.10
A meta-analysis of spurious associations between type D personality and cardiovascular disease endpoints. Ann Behav Med (2012) 2.08
Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study. Clin J Pain (2007) 2.07
Social support and self-care of patients with heart failure. Ann Behav Med (2008) 2.06
Personalized oxycodone dosing: using pharmacogenetic testing and clinical pharmacokinetics to reduce toxicity risk and increase effectiveness. Pain Med (2014) 2.05
Routine screening for depression in patients with coronary heart disease never mind. J Am Coll Cardiol (2009) 1.99
Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report. Psychosom Med (2006) 1.96
Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations. Pain (2012) 1.88
Use of complementary and alternative medicine and prayer among a national sample of cancer survivors compared to other populations without cancer. Complement Ther Med (2006) 1.85
Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain (2010) 1.84
Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors. Cancer (2009) 1.84
Quality of care indicators for gout management. Arthritis Rheum (2004) 1.77
The impact of modified Hatha yoga on chronic low back pain: a pilot study. Altern Ther Health Med (2004) 1.75
Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance. Am J Cardiol (2009) 1.68
Prediction of mortality in type 2 diabetes from health-related quality of life (ZODIAC-4). Diabetes Care (2008) 1.62
Off-resonance angiography: a new method to depict vessels--phantom and rabbit studies. Radiology (2008) 1.56
Apples don't fall far from the tree: influences on psychotherapists' adoption and sustained use of new therapies. Psychiatr Serv (2009) 1.53
Invited commentary: personality as a causal factor in cancer risk and mortality--time to retire a hypothesis? Am J Epidemiol (2010) 1.46
The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men. Clin Trials (2014) 1.46
Rethinking recommendations for screening for depression in primary care. CMAJ (2011) 1.46
Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy. AIDS (2002) 1.44
Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. JAMA (2011) 1.44
Effect of marital quality on eight-year survival of patients with heart failure. Am J Cardiol (2006) 1.44
Side effects of opioids during short-term administration: effect of age, gender, and race. Clin Pharmacol Ther (2003) 1.44
Symptom burden among cancer survivors: impact of age and comorbidity. J Am Board Fam Med (2007) 1.43
Normal triglyceride levels despite insulin resistance in African Americans: role of lipoprotein lipase. Metabolism (2005) 1.43
Development and psychometric testing of an instrument designed to measure chronic pain in dogs with osteoarthritis. Am J Vet Res (2007) 1.41
High incidence of insulin resistance and dysglycemia amongst nondiabetic cardiac surgical patients. Ann Thorac Surg (2012) 1.41
Pain intensity rating training: results from an exploratory study of the ACTTION PROTECCT system. Pain (2016) 1.39
De qi: Chinese acupuncture patients' experiences and beliefs regarding acupuncture needling sensation--an exploratory survey. Acupunct Med (2007) 1.36
Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using "positive contrast" magnetic resonance imaging. J Am Coll Cardiol (2008) 1.35
Sex differences in visceral adipose tissue volume among African Americans. Am J Clin Nutr (2002) 1.35
Paper and plastic in daily diary research: Comment on Green, Rafaeli, Bolger, Shrout, and Reis (2006). Psychol Methods (2006) 1.31
Physicians' perspectives on prescribing benzodiazepines for older adults: a qualitative study. J Gen Intern Med (2007) 1.30
Distinct trajectories of perinatal depressive symptomatology: evidence from growth mixture modeling. Am J Epidemiol (2008) 1.29
Clinical trial did not demonstrate benefits of screening patients with cancer for distress. J Clin Oncol (2011) 1.29
Importance of subsyndromal symptoms of depression in elderly patients. Am J Geriatr Psychiatry (2005) 1.28
Depressive symptoms as predictors of mortality in patients with COPD. Chest (2008) 1.25
Improving the pharmacologic management of pain in older adults: identifying the research gaps and methods to address them. Pain Med (2011) 1.25
Does evidence support the American Heart Association's recommendation to screen patients for depression in cardiovascular care? An updated systematic review. PLoS One (2013) 1.25
Postpartum physical symptoms in new mothers: their relationship to functional limitations and emotional well-being. Birth (2008) 1.24
Finding what is not there: unwarranted claims of an effect of psychosocial intervention on recurrence and survival. Cancer (2009) 1.20
Experience of trauma, distress, and posttraumatic stress disorder among breast cancer patients. Psychosom Med (2004) 1.20
Screening for depression in medical care: pitfalls, alternatives, and revised priorities. J Psychosom Res (2003) 1.19
A randomized, controlled study of Internet peer-to-peer interactions among women newly diagnosed with breast cancer. Psychooncology (2010) 1.18
Quantitative ischemia detection during cardiac magnetic resonance stress testing by use of FastHARP. Circulation (2003) 1.14
Use of an activity monitor to detect response to treatment in dogs with osteoarthritis. J Am Vet Med Assoc (2010) 1.14
Efficiency of a two-item pre-screen to reduce the burden of depression screening in pregnancy and postpartum: an IMPLICIT network study. J Am Board Fam Med (2008) 1.14
Feasibility trial of electroacupuncture for aromatase inhibitor--related arthralgia in breast cancer survivors. Integr Cancer Ther (2009) 1.13
Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study. BMJ (2012) 1.11
Peer-support in coping with medical uncertainty: discussion of oophorectomy and hormone replacement therapy on a web-based message board. Psychooncology (2007) 1.11
Optimizing suicide prevention programs and their implementation in Europe (OSPI Europe): an evidence-based multi-level approach. BMC Public Health (2009) 1.10
Screening for depression in primary care: will one or two items suffice? Eur Arch Psychiatry Clin Neurosci (2004) 1.10
High frame-rate simultaneous bilateral breast DCE-MRI. Magn Reson Med (2007) 1.09
Iyengar Yoga versus Enhanced Usual Care on Blood Pressure in Patients with Prehypertension to Stage I Hypertension: a Randomized Controlled Trial. Evid Based Complement Alternat Med (2011) 1.08
Older patient perspectives on long-term anxiolytic benzodiazepine use and discontinuation: a qualitative study. J Gen Intern Med (2007) 1.08
Pregnancy-related discontinuation of antidepressants and depression care visits among Medicaid recipients. Psychiatr Serv (2010) 1.07
Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges. J Pain (2013) 1.06
Integrating Clinical Pharmacokinetics, Pharmacogenetics, and Quantitative Cytochrome P450 Polymorphic Gene Drug-Drug Interactions (DDIs). Pain Physician (2015) 1.06
Hot flashes and panic attacks: a comparison of symptomatology, neurobiology, treatment, and a role for cognition. Psychol Bull (2008) 1.06
Ineffectiveness of reverse wording of questionnaire items: let's learn from cows in the rain. PLoS One (2013) 1.05
Measurement of a model of implementation for health care: toward a testable theory. Implement Sci (2012) 1.05
An assessment of suicide in an urban VA Medical Center. Psychiatry (2002) 1.04
What do psychotherapists really do in practice? An Internet study of over 2,000 practitioners. Psychotherapy (Chic) (2010) 1.04